Hatch, Harkin Call For Withdrawal of NDI Draft Guidance

Sens. Hatch and Harkin ask FDA to craft a new document to replace the current NDI notification draft guidance, recommending the agency “provide needed clarification” on what constitutes an NDI.

Sens. Orrin Hatch and Tom Harkin say FDA’s new dietary ingredient notification draft guidance undermines the Dietary Supplement Health and Education Act and should be withdrawn.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America